FOX8 Cleveland

Baebies Receives FDA 510(k) Clearance for G6PD Test on FINDER Platform

DURHAM, N.C., Nov. 9, 2022 /PRNewswire/ -- Baebies has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its rapid, point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) ...
Business Wire

MedTest Dx Manufactures the Only FDA Approved Quantitative Test for G6PD, Critical when Considering COVID-19 Treatment with Chloroquine and Hydroxychloroquine

-Accurate, Plug and Play Test Measures G6PD Activity in Whole Blood, Detecting Both Presence and Severity of G6PD Deficiency, Providing Key Insight to Inform Drug Therapy Options CANTON, ...
technologynetworks

MedTest Dx Manufacturing FDA Approved Quantitative Test for G6PD for COVID-19 Treatment

MedTest Dx, Inc., an established solution provider for clinical diagnostic testing, is providing a critical tool in the fight against COVID-19 with its Pointe Scientific-branded assay for the highly ...
Nature

Glucose-6-phosphate dehydrogenase (G6PD) mutations in Cambodia: G6PD Viangchan (871G>A) is the most common variant in the Cambodian population

We conducted a survey of malaria diagnoses and glucose-6-phosphate dehydrogenase (G6PD) testing in remote areas of Cambodia. Blood specimens from 670 people were collected by the finger-prick method.